EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Testicular ultrasonographic features predict future risk for bilateral testicular germ cell tumour: A long‐term single centre follow‐up study

Marta Tenuta iD, Paola Mazzotta, Franz Sesti iD, Francesco Angelini, Alain J Gelibter, Iolanda Speranza, Donatella Paoli iD, Francesco Lombardo iD, Antonella Anzuini, Fabio Massimo Magliocca, Giorgio Franco, Enrico Cortesi und 5 weitere

Andrology · 2025

DOI: 10.1111/andr.13704 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Andrology, 2025. Verfasst von Marta Tenuta und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Andrology, Department of Experimental Medicine, Sapienza University, Rome, Italy. Hauptthemen laut MEDLINE: Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal, Testis, Neoplasms, Second Primary. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Italian Ministry of Health: PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic Origin (PROMETEO) project, European Union Next Generation EU through the Italian Ministry of University and Research: PNRR M4C2-I1.3 Project PE_00000019 "HEALITALIA".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bilateral testicular germ cell tumours (B‐GCT) are rare, with an incidence of 2–5%, and can be classified as synchronous (sB‐GCT) or metachronous (mB‐GCT). Our study aimed to identify clinical, biochemical, and radiological risk factors for mB‐GCT in a cohort of patients with GCT at a single tertiary referral centre.

Methods

This retrospective case‐control study included patients with GCT referred to Policlinico Umberto I—Sapienza University of Rome, from 2005 to 2023. We evaluated clinical history, testicular ultrasound features, hormone levels, semen analysis, histological characteristics, staging, and treatments. mB‐GCTs were compared with unilateral GCT patients with a follow‐up longer than the median time‐to‐onset of the second tumour.

Results

Of 319 patients, 52 experienced B‐GCT, with a median time‐to‐onset of the second tumour of 62 months (range: 8–229). The mB‐GCT group showed higher gonadotropin levels (FSH 13.6mUI/mL vs. 7.4mUI/mL, p < 0.001; LH 6.6mUI/mL vs. 3.9mUI/mL, p = 0.004), lower sperm concentration (27 × 10 6 /ejaculate vs. 78 × 10 6 /ejaculate, p = 0.009), smaller residual testis volume (10.4 mL vs. 16.3 mL, p < 0.001), more inhomogeneous echotexture [57.5% vs. 14%, p < 0.001], and presence of microlithiasis (75% vs. 19.5%, p < 0.001). Kaplan–Meier curves confirmed that ultrasound features of the residual testis increased the cumulative risk of developing a second tumour. Microlithiasis was a strong independent predictor (OR 30.712, 95% CI 3.357–280.942, p = 0.002).

Conclusions

Histological features of the first tumour or its treatment do not influence the onset of a second tumour. However, low residual testis volume, inhomogeneous echotexture, and microlithiasis significantly increase this risk. A comprehensive evaluation of the residual testis at baseline is essential for developing a personalised surveillance programme in GCT survivors, with regular ultrasound follow‐up recommended beyond the conventional 5‐year limit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Testicular NeoplasmsNeoplasms, Germ Cell and EmbryonalTestisNeoplasms, Second PrimaryHumansMaleAdultRetrospective StudiesUltrasonographyFollow-Up StudiesCase-Control StudiesMiddle AgedRisk FactorsYoung Adult

Stichwörter der Autor:innen

bilateral testicular tumoursmicrolithiasismixed germ cell tumoursseminomatesticular ultrasound

Autor:innen und Institutionen

  • Division of Endocrinology and Andrology, Department of Experimental Medicine, Sapienza University, Rome, Italy.
  • Division of Oncology B, Department of Radiological, Oncological and Anatomopathological Sciences, Sapienza University, Rome, Italy.
  • Division of Oncology A, Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University, Latina, Italy.
  • Department of Radiological, Oncological and Pathological Sciences, Sapienza University, Rome, Italy.
  • Department of Maternal and Child Health and Urological Sciences, Sapienza University, Rome, Italy.

ORCID-Profile: Marta Tenuta, Franz Sesti, Donatella Paoli, Francesco Lombardo, Daniele Gianfrilli, Andrea M Isidori, Carlotta Pozza

Förderung

  • Italian Ministry of Health: PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic Origin (PROMETEO) project
  • European Union Next Generation EU through the Italian Ministry of University and Research: PNRR M4C2-I1.3 Project PE_00000019 "HEALITALIA"

Zitieren

APA

Tenuta, M., Mazzotta, P., Sesti, F., Angelini, F., Gelibter, A. J., Speranza, I., Paoli, D., Lombardo, F., Anzuini, A., Magliocca, F. M., Franco, G., Cortesi, E., Santini, D., Lenzi, A., Gianfrilli, D., Isidori, A. M., & Pozza, C. (2025). Testicular ultrasonographic features predict future risk for bilateral testicular germ cell tumour: A long‐term single centre follow‐up study. Andrology. https://doi.org/10.1111/andr.13704

Vancouver

Tenuta M, Mazzotta P, Sesti F, Angelini F, Gelibter AJ, Speranza I, et al. Testicular ultrasonographic features predict future risk for bilateral testicular germ cell tumour: A long‐term single centre follow‐up study. Andrology. 2025. doi:10.1111/andr.13704

BibTeX
@article{Tenuta2025,
  author = {Tenuta, Marta and Mazzotta, Paola and Sesti, Franz and Angelini, Francesco and Gelibter, Alain J and Speranza, Iolanda and Paoli, Donatella and Lombardo, Francesco and Anzuini, Antonella and Magliocca, Fabio Massimo and Franco, Giorgio and Cortesi, Enrico and Santini, Daniele and Lenzi, Andrea and Gianfrilli, Daniele and Isidori, Andrea M and Pozza, Carlotta},
  title = {Testicular ultrasonographic features predict future risk for bilateral testicular germ cell tumour: A long‐term single centre follow‐up study},
  journal = {Andrology},
  year = {2025},
  doi = {10.1111/andr.13704}
}
Kostenlos starten →